Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 11.91 as of Sunday, July 26, 2026.
Forward PE Ratio (11.91) = Close Price ($79.86) / Consensus Forward EPS ($6.55)
FORWARD PE RATIO
11.91
SECTOR MEDIAN · HEALTHCARE
18.38
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
-35.18%
vs the sector median at left
Solventum Corporation
Market Cap
$13.83B
Forward PE Ratio
11.91
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Solventum Corporation (SOLV) | $13.83B | 11.91 |
| The Cooper Companies, Inc. (COO)vs › | $13.88B | 15.17 |
| DaVita Inc. (DVA)vs › | $15.31B | 15.82 |
| Revvity, Inc. (RVTY)vs › | $12.34B | 21.08 |
| Align Technology, Inc. (ALGN)vs › | $12.29B | 14.69 |
| Baxter International Inc. (BAX)vs › | $11.93B | 11.66 |
| Insulet Corp. (PODD)vs › | $11.58B | 25.20 |
| Bio-Techne Corporation (TECH)vs › | $11.22B | 37.23 |
| Charles River Laboratories International, Inc. (CRL)vs › | $10.93B | 20.40 |
| Medpace Holdings, Inc. (MEDP)vs › | $16.81B | 34.28 |
Trailing P/E
9.6
reported TTM EPS
Forward P/E
11.9
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $6.55 implies -19.8% EPS decline vs the reported trailing $8.17.
At today's $79.86 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $6.55 | $6.52 – $6.57 | 10 | 12.2x |
| 2027-12-31 | $7.10 | $6.84 – $7.32 | 10 | 11.2x |
| 2028-12-31 | $7.81 | $3.19 – $10.69 | 6 | 10.2x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
